ConductScience.org, home

Paper18400400

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.

Crofford LJ and 6 others. Pain, 2008. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Papers, record 18400400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18400400

Download JSON
Disease
fibromyalgia103 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.
PubMed
Journal
Pain
PubMed
Year
2008
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
6.47
iCite
Revised in PubMed
2022-03-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crofford LJLeslie J
2Mease PJPhilip J
3Simpson SLSusan L
4Young JP JrJames P
5Martin SASusan A
6Haig GMGeorge M
7Sharma UUma

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clinical ProtocolsMajor topic
Clinical Trials as TopicMajor topic
FibromyalgiaMajor topic
Outcome Assessment, Health CareMajor topic
Placebo EffectMajor topic
gamma-Aminobutyric AcidMajor topic
Adrenergic Uptake Inhibitors
Analgesics
Double-Blind Method
Female
Humans
Longitudinal Studies
Male
Middle Aged
Pregabalin
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01397006Fibromyalgia of Less Than One Year Duration. Study of PregabalinResults

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in18384959Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.https://conductscience.org/library/papers/18384959PubMed
Comment in18684565Determining long-term efficacy for treatment of chronic pain in fibromyalgia patients.https://conductscience.org/library/papers/18684565PubMed
Comment in18852724Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyalgia?https://conductscience.org/library/papers/18852724PubMed

Download CSV of comments and corrections

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
42498694Gabapentinoids-duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting.Br J Clin Pharmacol2026https://conductscience.org/library/papers/42498694PubMed
42097637Impact of treatment duration on the effectiveness of opioid analgesia: a systematic review and meta-analysis.Br J Gen Pract2026https://conductscience.org/library/papers/42097637PubMed
40084994Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis.Rheumatology (Oxford)2025https://conductscience.org/library/papers/40084994PubMed
39516528Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial.Sci Rep2024https://conductscience.org/library/papers/39516528PubMed
38131736Assessing Ethnic Minority Representation in Fibromyalgia Clinical Trials: A Systematic Review of Recruitment Demographics.Int J Environ Res Public Health2023https://conductscience.org/library/papers/38131736PubMed
37127914Emerging treatment for Sjögren's disease: a review of recent phase II and III trials.Expert Opin Emerg Drugs2023https://conductscience.org/library/papers/37127914PubMed
36529848Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval.Drugs2023https://conductscience.org/library/papers/36529848PubMed
35840702Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis.Sci Rep2022https://conductscience.org/library/papers/35840702PubMed
35210848Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review.J Pain Res2022https://conductscience.org/library/papers/35210848PubMed
32669869Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia.J Pain Res2020https://conductscience.org/library/papers/32669869PubMed
29623147Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway.Pain Res Manag2018https://conductscience.org/library/papers/29623147PubMed
28778847
Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid - Pregabalin Combination for the Treatment of Fibromyalgia Pain.
JMIR Res Protoc2017https://conductscience.org/library/papers/28778847PubMed
28383710
The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain.
Pain Med2017https://conductscience.org/library/papers/28383710PubMed
27790003Management strategies for fibromyalgia.Open Access Rheumatol2011https://conductscience.org/library/papers/27790003PubMed
27789991Advances in diagnostic and treatment options in patients with fibromyalgia syndrome.Open Access Rheumatol2009https://conductscience.org/library/papers/27789991PubMed
27684492Pregabalin for pain in fibromyalgia in adults.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27684492PubMed
27107994An overview of treatment approaches for chronic pain management.Rheumatol Int2017https://conductscience.org/library/papers/27107994PubMed
26937205Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia.Drug Healthc Patient Saf2016https://conductscience.org/library/papers/26937205PubMed
26922414Fibromyalgia Pathogenesis and Treatment Options Update.Curr Pain Headache Rep2016https://conductscience.org/library/papers/26922414PubMed
26112278Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.Pediatr Rheumatol Online J2015https://conductscience.org/library/papers/26112278PubMed

See all 68 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
PREGABALINCHEMBL1059Results1https://conductscience.org/library/drugs/CHEMBL1059

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18400400

GET https://conductscience.org/api/papers/v1/18400400/cited_by?page=2